Tong Ren Tang Technologies Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tong Ren Tang Technologies Company Limited with three other
companies in this sector in China:
Hubei Jumpcan Pharmaceutical Co Ltd
sales of 3.74 billion Chinese Renmimbi [US$555.03 million]
of which 96%
was Industrial Manufacturing),
Northeast Pharmaceutical Group Co., Ltd.
(3.83 billion Chinese Renmimbi [US$568.17 million]
of which 62%
was Pharmaceutical Products), and
Guizhou Xinbang Pharmaceutical Company Limited
(4.18 billion Chinese Renmimbi [US$619.63 million]
of which 60%
was Pharmaceutical industry).
Tong Ren Tang Technologies Company Limited reported sales of 3.99 billion Chinese Renmimbi (US$591.49 million)
December of 2015.
increase of 19.3%
versus 2014, when the company's sales were 3.34 billion Chinese Renmimbi.
Sales at Tong Ren Tang Technologies Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 153%).
Sales of All Other Segments saw an increase
that was more than double the company's growth rate: sales were up
179.1% in 2015, from
259.28 million Chinese Renmimbi to 723.66 million Chinese Renmimbi.
Tong Ren Tang Technologies Company Limited also saw significant increases in sales in
Tong Ren Tang Chinese Medicine (up 29.7% to 783.13 million Chinese Renmimbi)